Cargando…

Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer

Detalles Bibliográficos
Autores principales: Lin, Jenny, Frey, Melissa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683680/
https://www.ncbi.nlm.nih.gov/pubmed/34977314
http://dx.doi.org/10.1016/j.gore.2021.100843
_version_ 1784617468906438656
author Lin, Jenny
Frey, Melissa K.
author_facet Lin, Jenny
Frey, Melissa K.
author_sort Lin, Jenny
collection PubMed
description
format Online
Article
Text
id pubmed-8683680
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86836802021-12-30 Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer Lin, Jenny Frey, Melissa K. Gynecol Oncol Rep Correspondence Elsevier 2021-07-29 /pmc/articles/PMC8683680/ /pubmed/34977314 http://dx.doi.org/10.1016/j.gore.2021.100843 Text en © 2021 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Lin, Jenny
Frey, Melissa K.
Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
title Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
title_full Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
title_fullStr Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
title_full_unstemmed Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
title_short Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
title_sort reply to dr. witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683680/
https://www.ncbi.nlm.nih.gov/pubmed/34977314
http://dx.doi.org/10.1016/j.gore.2021.100843
work_keys_str_mv AT linjenny replytodrwitjesregardinguniversaltumorgenomicsequencingasaprescreenforgermlinegenetictestinginpatientsdiagnosedwithovariancancer
AT freymelissak replytodrwitjesregardinguniversaltumorgenomicsequencingasaprescreenforgermlinegenetictestinginpatientsdiagnosedwithovariancancer